KARMEN MAYTUM: Open Payments
NPI 1467981571 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 18 payments from 5 companies in 2025. Trend: 2023 $18 · 2024 $20 · 2025 $489
Food & beverage: $405Education: $84
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 6 | $150 |
| ABBVIE INC. | 5 | $148 |
| PFIZER INC. | 5 | $87 |
| Janssen Biotech, Inc. | 1 | $84 |
| Celltrion USA Inc. | 1 | $21 |
Products named: Sucraid, SKYRIZI, TREMFYA, VELSIPITY, RINVOQ, XELJANZ, VEGZELMA.
Industry payments across IL — which companies pay providers there.
